Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Anteris Technologies Global Corp.

AVR•NASDAQ
Healthcare
Medical - Devices
$6.15
$0.39(6.77%)
U.S. Market is Open • 12:27

Anteris Technologies Global Corp. (AVR) Stock Overview

Explore Anteris Technologies Global Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap186.9M
P/E Ratio-1.59
EPS (TTM)$-2.60
ROE-2.51%
Fundamental Analysis

AI Price Forecasts

1 Month$14.84
3 Months$6.61
1 Year Target$7.76

AVR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anteris Technologies Global Corp. (AVR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.59 and a market capitalization of 186.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.39%
5-Day Change
N/A
1-Month Change
-1.22%
3-Month Change
68.05%
6-Month Change
59.55%
Year-to-Date (YTD) Change
15.45%
1-Year Change
-31.32%
3-Year Change
1.43%
5-Year Change
1.43%
All-Time (Max) Change
1.43%

Contact Information

https://anteristech.com
61 13 0055 0310
Toowong Tower, Toowong, QLD, 4066

Company Facts

1,360 Employees
IPO DateDec 13, 2024
CountryAU
Actively Trading

Frequently Asked Questions